Literature DB >> 2443159

Synthetic peptides used to locate the alpha-bungarotoxin binding site and immunogenic regions on alpha subunits of the nicotinic acetylcholine receptor.

S Ralston1, V Sarin, H L Thanh, J Rivier, J L Fox, J Lindstrom.   

Abstract

Synthetic peptides corresponding to 57% of the sequence of alpha subunits of acetylcholine receptors from Torpedo californica electric organ and extending from the NH2 to the COOCH terminus have been synthesized. The alpha-bungarotoxin binding site on denatured alpha subunits was mapped within the sequence alpha 185-199 by assaying binding of 125I-alpha-bungarotoxin to slot blots of synthetic peptides. Further studies showed that residues in the sequence alpha 190-194, especially cysteines-alpha 192, 193, were critical for binding alpha-bungarotoxin. Reduction and alkylation studies suggested that these cysteines must be disulfide linked for alpha-bungarotoxin to bind. Binding sites for serum antibodies to native receptors or alpha subunits were mapped by indirect immunoprecipitation of 125I-peptides. Several antigenic sequences were identified, but a synthetic peptide corresponding to the main immunogenic region (which is highly conformation dependent) was not identified.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443159     DOI: 10.1021/bi00386a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Alpha-bungarotoxin binding to acetylcholine receptor membranes studied by low angle X-ray diffraction.

Authors:  Howard S Young; Leo G Herbette; Victor Skita
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

Review 2.  Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators.

Authors:  E L Ochoa; A Chattopadhyay; M G McNamee
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

3.  Two-dimensional measurement of proton T1rho relaxation in unlabeled proteins: mobility changes in alpha-bungarotoxin upon binding of an acetylcholine receptor peptide.

Authors:  Abraham O Samson; Jordan H Chill; Jacob Anglister
Journal:  Biochemistry       Date:  2005-08-16       Impact factor: 3.162

Review 4.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 5.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

6.  Epitopes expressed in myasthenia gravis (MG) thymomas are not recognized by patients' T cells or autoantibodies.

Authors:  N Nagvekar; L W Jacobson; N Willcox; A Vincent
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

7.  Multipoint attachment of ligands to the nicotinic acetylcholine receptor from torpedo electric organ.

Authors:  A Maelicke; B M Conti-Tronconi
Journal:  J Protein Chem       Date:  1989-06

Review 8.  Molecular studies of the neuronal nicotinic acetylcholine receptor family.

Authors:  J Lindstrom; R Schoepfer; P Whiting
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

9.  Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit.

Authors:  M A Schmidt; W Schmidt
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

10.  Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus.

Authors:  P L Schwimmbeck; T Dyrberg; D B Drachman; M B Oldstone
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.